Hologic Files 8-K on Financial Results & Operations
Ticker: HOLX · Form: 8-K · Filed: Feb 1, 2024 · CIK: 859737
Complexity: simple
Sentiment: neutral
Topics: financial-results, 8-K, operations, corporate-filing
TL;DR
**Hologic just dropped an 8-K on financial results, get ready for potential stock movement.**
AI Summary
Hologic, Inc. filed an 8-K on February 1, 2024, to report its results of operations and financial condition. This filing indicates that the company is providing an update on its financial performance, likely related to its most recent quarter or fiscal period. For investors, this matters because it offers crucial insights into the company's profitability, revenue growth, and overall financial health, which can directly influence stock price and future investment decisions.
Why It Matters
This filing provides investors with the latest financial performance data for Hologic, Inc., enabling them to assess the company's health and make informed investment decisions.
Risk Assessment
Risk Level: medium — The risk level is medium because the filing itself doesn't contain negative news, but the actual financial results, once disclosed, could be positive or negative, impacting the stock.
Analyst Insight
A smart investor would await the full financial statements and results mentioned in this 8-K to be released, then analyze them for revenue, profit, and guidance changes before making any investment decisions regarding HOLX.
Key Players & Entities
- HOLOGIC, INC. (company) — the registrant filing the 8-K
- February 1, 2024 (date) — date of earliest event reported and filing date
- 001-36214 (other) — Commission File Number
- HOLX (other) — trading symbol for Hologic, Inc.
- The Nasdaq Stock Market LLC (other) — exchange where Hologic's common stock is registered
FAQ
What is the purpose of Hologic, Inc.'s 8-K filing dated February 1, 2024?
The 8-K filing by Hologic, Inc. on February 1, 2024, is primarily for reporting 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' as per the Item Information section.
What is Hologic, Inc.'s trading symbol and where is its common stock registered?
Hologic, Inc.'s trading symbol is HOLX, and its common stock, with a $.01 par value, is registered on The Nasdaq Stock Market LLC, as stated in the 'Securities registered pursuant to Section 12(b) of the Act' section.
What is the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 1, 2024, as indicated by the 'Date of Report (Date of earliest event reported)' field.
Is Hologic, Inc. considered an emerging growth company according to this filing?
No, Hologic, Inc. is not indicated as an emerging growth company, as the checkbox for 'Emerging growth company' is not marked in the filing.
What is the business address and phone number of Hologic, Inc. as listed in the filing?
Hologic, Inc.'s business address is 250 Campus Drive, Marlborough, Massachusetts 01752, and its business phone number is (508) 263-2900, according to the 'BUSINESS ADDRESS' section of the filing.
Filing Stats: 596 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-02-01 16:02:02
Filing Documents
- a53890608.htm (8-K) — 32KB
- a53890608ex99_1.htm (EX-99.1) — 656KB
- image0.jpg (GRAPHIC) — 1KB
- 0001157523-24-000153.txt ( ) — 860KB
- holx-20240201.xsd (EX-101.SCH) — 4KB
- holx-20240201_lab.xml (EX-101.LAB) — 22KB
- holx-20240201_pre.xml (EX-101.PRE) — 16KB
- a53890608_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On February 1, 2024, Hologic, Inc. issued a press release announcing its financial results for the first quarter ended December 30, 2023. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference. Limitation on Incorporation by Reference. The information furnished in this Item 2.02, including the press release attached hereto as Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as set forth by specific reference in such a filing. Cautionary Note Regarding Forward-Looking Statements. Except for historical information contained in the press release attached as an exhibit hereto, the press release contains forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the press release regarding these forward-looking statements.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release dated February 1, 2024, of Hologic, Inc. announcing its financial results for the first quarter ended December 30, 2023 . 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 1, 2024 HOLOGIC, INC. By: /s/ Karleen M. Oberton Karleen M. Oberton Chief Financial Officer